PTCT · Ptc Therapeutics, Inc. · Share Buybacks
$64.78
-0.18 (-0.28%)
At close · Sep 30
View the 10-K filed Feb 19, 2026
Return incl. dividend (before tax)
Customer concentration
— top 4 customers 10% of revenue
4 customers — 10% of revenue (2025)
“During 2025, four of our distributors each accounted for over 10% of our net product sales.”
Market Cap
$5.23B
Shares
83.46M
Volume · Sep 30
1.04M
Avg daily vol (3M)
1.29M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2019-08 | — | $125,000,000 | $93,000,000 as of 2026-06-30 | — | 10-Q , filed 2026-07-30 |
Key facts
CIK
1070081
CUSIP
69366J200
13F (30d)
14 filings
11 filers
Visit website
Investor relations